Laminar Pharmaceuticals

Laminar Pharmaceuticals, based in Palma de Mallorca, Spain, is a biotechnology company. Laminar Pharma is a biopharmaceutical company developing 'melitherapy', a therapeutic approach targeting membrane lipids rather than proteins or DNA, for conditions including cancer and Alzheimer's disease. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing LAM561 in glioma & glioblastoma. The largest, NCT04250922 (LAM561 With RT and TMZ for Adults With Glioblastoma), plans to enrol 144 participants (actual). Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.